CA2326402A1 - Preparation of human papillomavirus e1 having helicase activity and method therefor - Google Patents

Preparation of human papillomavirus e1 having helicase activity and method therefor Download PDF

Info

Publication number
CA2326402A1
CA2326402A1 CA002326402A CA2326402A CA2326402A1 CA 2326402 A1 CA2326402 A1 CA 2326402A1 CA 002326402 A CA002326402 A CA 002326402A CA 2326402 A CA2326402 A CA 2326402A CA 2326402 A1 CA2326402 A1 CA 2326402A1
Authority
CA
Canada
Prior art keywords
leu
seq
ser
asp
thr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002326402A
Other languages
English (en)
French (fr)
Inventor
Alex Pelletier
Chris M. Farnet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Canada Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2326402A1 publication Critical patent/CA2326402A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90Isomerases (5.)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/20011Papillomaviridae
    • C12N2710/20022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002326402A 1998-05-01 1999-04-28 Preparation of human papillomavirus e1 having helicase activity and method therefor Abandoned CA2326402A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8394298P 1998-05-01 1998-05-01
US60/083,942 1998-05-01
PCT/CA1999/000389 WO1999057283A1 (en) 1998-05-01 1999-04-28 Preparation of human papillomavirus e1 having helicase activity and method therefor

Publications (1)

Publication Number Publication Date
CA2326402A1 true CA2326402A1 (en) 1999-11-11

Family

ID=22181652

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002326402A Abandoned CA2326402A1 (en) 1998-05-01 1999-04-28 Preparation of human papillomavirus e1 having helicase activity and method therefor

Country Status (9)

Country Link
US (1) US6306580B1 (enExample)
EP (1) EP1073750A1 (enExample)
JP (1) JP2002513813A (enExample)
AU (1) AU767903B2 (enExample)
CA (1) CA2326402A1 (enExample)
HU (1) HUP0101396A3 (enExample)
IL (1) IL139270A0 (enExample)
NZ (1) NZ508519A (enExample)
WO (1) WO1999057283A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE387500T1 (de) * 1998-07-21 2008-03-15 Boehringer Ingelheim Ca Ltd Regionen des papillomavirus-e1-helikase beteiligt an e1 oligomerisierung
MXPA01012921A (es) 1999-06-17 2002-09-18 Boehringer Ingelheim Ltd Nuevo ensayo de atpasa.
GB0017990D0 (en) * 2000-07-21 2000-09-13 Glaxo Group Ltd Papilloma virus sequences
US7167801B2 (en) 2001-07-12 2007-01-23 Boehringer Ingelheim (Canada) Ltd. Method of identifying potential inhibitors of human papillomavirus protein E2 using x-ray atomic coordinates
AU2003215244A1 (en) * 2002-02-14 2003-09-04 Curagen Corporation Complexes and methods of using same
USD1070308S1 (en) * 2023-07-13 2025-04-15 Wolverine Outdoors, Inc. Footwear sole
USD1067594S1 (en) * 2023-07-13 2025-03-25 Wolverine Outdoors, Inc. Footwear sole
USD1067593S1 (en) * 2023-07-13 2025-03-25 Wolverine Outdoors, Inc. Footwear sole

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464936A (en) 1990-12-21 1995-11-07 Cetus Oncology Corporation Compositions for identification of papillomavirus replication inhibitors

Also Published As

Publication number Publication date
AU3592399A (en) 1999-11-23
HUP0101396A3 (en) 2006-03-28
AU767903B2 (en) 2003-11-27
NZ508519A (en) 2003-12-19
IL139270A0 (en) 2001-11-25
WO1999057283A1 (en) 1999-11-11
EP1073750A1 (en) 2001-02-07
HUP0101396A2 (hu) 2001-08-28
US6306580B1 (en) 2001-10-23
JP2002513813A (ja) 2002-05-14

Similar Documents

Publication Publication Date Title
Hughes et al. E1 protein of human papillomavirus is a DNA helicase/ATPase
CN100535123C (zh) 蛋白酶检测系统
Vande Pol et al. Association of bovine papillomavirus type 1 E6 oncoprotein with the focal adhesion protein paxillin through a conserved protein interaction motif
Andrés et al. African swine fever virus protease, a new viral member of the SUMO-1-specific protease family
US6825176B2 (en) E2 displacement assay for identifying inhibitors of HPV
Webster et al. Role of preterminal protein processing in adenovirus replication
AU767903B2 (en) Preparation of human papillomavirus E1 having helicase activity and method therefor
CA2439176A1 (en) Assay for identifying inhibitors of the rna dependent rna polymerase (ns5b) of hcv
AU714821B2 (en) Methods, kits, and compositions for diagnosing papillomavirus infection
Rocque et al. Replication-associated activities of purified human papillomavirus type 11 E1 helicase
US6916622B2 (en) Regions of papilloma virus E1 helicase involved in E1 oligomerization
MXPA00010584A (en) Preparation of human papillomavirus e1 having helicase activity and method therefor
US6322792B1 (en) Rhadino virus LANA acts in trans on a unit of rhadino virus DNA to mediate efficient episome persistance
EP0938555B1 (en) Constructs and complexes of cyclin e
AU2004200590A1 (en) Regions of papilloma virus E1 helicase involved in E1 oligomerization
MXPA01000693A (en) Regions of papilloma virus e1 helicase involved in e1 oligomerization
GB2311069A (en) Primase isolated from human cytomegalovirus (HCMV)
AU2002244566B2 (en) Assay for identifying inhibitors of the RNA dependent RNA polymerase (NS5B) of HCV
WO1999057536A2 (en) Cyclin activation kinase (cak) from human pathogens, and uses related thereto
AU2002244566A1 (en) Assay for identifying inhibitors of the RNA dependent RNA polymerase (NS5B) of HCV
JPH08304403A (ja) 抗クラミジア・ニューモニエ抗体の検出・測定方法及びその試薬、並びにクラミジア・ニューモニエ感染の診断薬

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued